CHAD WINTERS: Open Payments
NPI 1710942891 · LENEXA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$976 in 63 payments from 19 companies in 2025. Trend: 2023 $1,552 · 2024 $1,138 · 2025 $976
Food & beverage: $976
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $183 |
| PFIZER INC. | 16 | $165 |
| Novo Nordisk Inc | 6 | $120 |
| Amgen Inc. | 4 | $67 |
| Lilly USA, LLC | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Kowa Pharmaceuticals America, Inc. | 3 | $45 |
| Lundbeck LLC | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $32 |
Products named: Wegovy, REXULTI, VRAYLAR, PREVNAR 20, NURTEC ODT, EVENITY, QULIPTA, UBRELVY.
Industry payments across KS — which companies pay providers there.
